Evidence map›Paper›PMID 38556586›Full record

ArticleMolecular biomedicine2024

Fat mass and obesity-associated protein (FTO) mediated m

Xi Wu, Yuan Fang, Yunru Gu, Haoyang Shen, Yangyue Xu, Tingting Xu, Run Shi, Duo Xu, Jingxin Zhang, Kai Leng and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular biomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. RNA mCell biology and toxicology · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. mFrontiers in cell and developmental biology · 2026
    Review
  12. Review
  13. The mMolecular biomedicine · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Xi Wu *Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People's Republic of China.
Yuan Fang *Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People's Republic of China.
Yunru Gu *Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People's Republic of China.
Haoyang ShenDepartment of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People's Republic of China.
Yangyue XuDepartment of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People's Republic of China.
Tingting XuDepartment of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People's Republic of China.
Run ShiDepartment of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People's Republic of China.
Duo XuDepartment of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People's Republic of China.
Jingxin ZhangDepartment of General Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang Clinic School of Nanjing Medical University, Zhenjiang, People's Republic of China.
Kai LengDepartment of Medical Informatics, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People's Republic of China.
Yongqian ShuDepartment of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People's Republic of China. yongqian_shu@163.com.
Pei MaDepartment of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People's Republic of China. mapei@njmu.edu.cn.
Jiangsu Province Hospital · CNNanjing Medical University · CN

Funding

National Natural Science Foundation of China 82172889National Natural Science Foundation of China 82173347
6 · The paper itself

Abstract

Gastric cancer (GC) is a common malignant tumor worldwide, especially in East Asia, with high incidence and mortality rate. Epigenetic modifications have been reported to participate in the progression of gastric cancer, among which m

Indexed as

Alpha-Ketoglutarate-Dependent Dioxygenase FTOCell ProliferationGene Expression Regulation, NeoplasticLarge Neutral Amino Acid-Transporter 1RNA, CircularStomach NeoplasmsAdenosineAnimalsCell Line, TumorFemaleHumansMaleMiceMice, NudePrognosisRNA MethylationAdenosineAlpha-Ketoglutarate-Dependent Dioxygenase FTOFTO protein, humanLarge Neutral Amino Acid-Transporter 1N-methyladenosineRNA, CircularSLC7A5 protein, humanTOR Serine-Threonine KinasesCircular RNA (circRNA)Fat mass and obesity-associated protein (FTO)Gastric Cancer (GC)N6-methyladinosine (m6A)Solute carrier family 7 member 5 (SLC7A5)

Identifiers

PMID38556586
PMCPMC10982225
OpenAlexW4393390765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.